| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |